Join
Live feed
·
INSIDERFilingvia Quantisnow
PLUS THERAPEUTICS Inc. logo

Director Andrews Ronald Asbury converted options into 922 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PSTV· PLUS THERAPEUTICS Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PSTV (PLUS THERAPEUTICS Inc.) and more on Quantisnow.